CompletedPhase 4

Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

Canada43,626 participantsStarted 2016-08-15

Plain-language summary

The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death or re-admission to hospital with 90 days of the index admission.

Who can participate

Age range29 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: ● All adult and pediatric patients with an index admission to the participating hospitals during study periods Exclusion Criteria: * neonates * physicians may opt out of the use of the allocated study fluid for a specific patient

What they're measuring

Number of participants that died or were readmitted to hospital

Timeframe: 90 days from index hospital admission

Trial details

NCT IDNCT04512950

SponsorOttawa Hospital Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06-13

View on ClinicalTrials.gov More Fluid Therapy trials